Posted at 00:44h
in
Author Interviews,
JAMA
MedicalResearch.com Interview with:
Wei-ping Zhou, MD, PhD
Department of Hepatic Surgery
Eastern Hepatobiliary Surgery Hospital
Shanghai, China
MedicalResearch.com: What are the main findings of the study?
Answer: The main finding is that Quantitative HBsAg can be used as a new prognostic factor of
Hepatocellular Carcinoma recurrence after partial hepatectomy in patients with a low HBV-DNA level.
